Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival-Reference-Cited by-同舟云学术

Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival

Published:2012-06 Issue:6 Volume:23 Page:1601-1607
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Italiano A.,Toulmonde M.,Cioffi A.,Penel N.,Isambert N.,Bompas E.,Duffaud F.,Patrikidou A.,Lortal B.,Le Cesne A.,Blay J.-Y.,Maki R.G.,Schwartz G.K.,Antonescu C.R.,Singer S.,Coindre J.-M.,Bui B.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/6/1601/402457/mdr485.pdf

Reference38 articles.

1. Pathology and genetics of tumours of soft tissue and bone;Fletcher,2002

2. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon;Italiano;Int J Cancer,2008

3. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data;Binh;Am J Surg Pathol,2005

4. Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours;Aleixo;J Clin Pathol,2009

5. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma;Coindre;Mod Pathol,2003

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 24-kilogram retroperitoneal liposarcoma surgical management: A case report;Surgery Case Reports;2024-11

2. Molecular characteristics and systemic treatment options of liposarcoma: A systematic review;Biomedicine & Pharmacotherapy;2024-09

3. Challenges in Diagnosis and Management: A Case of Abdominal Wall Liposarcoma;Cureus;2024-08-23

4. Giant mucinous liposarcoma of the abdominal cavity: A case report;Medicine;2024-08-16

5. A first-in-human phase I study of a novel MDM2/p53 inhibitor alrizomadlin in advanced solid tumors;ESMO Open;2024-08